171 results
Page 5 of 9
424B5
n89ytppg v7m1i5
22 Jan 20
Prospectus supplement for primary offering
5:31pm
8-K
EX-1.1
55m699tj
22 Jan 20
Adaptimmune Therapeutics plc Proposes Public Offering of American Depositary Shares
5:30pm
424B5
mc9f jk1xj1
21 Jan 20
Prospectus supplement for primary offering
5:21pm
8-K
EX-99.1
43p62ei22sn4strrr9gl
14 Jan 20
Astellas and Adaptimmune Enter into Agreement to Co-Develop and Co-Commercialize Stem-Cell Derived Allogeneic CAR-T and TCR T-Cell Therapies
6:17am
8-K
EX-10.1
g639h aqk7h0f2n
13 Jan 20
Adaptimmune Appoints Elliot Norry as Chief Medical Officer and Makes Changes to R&D Leadership
8:42am
8-K
6ektm11e4
1 Oct 19
Adaptimmune Announces Appointment of Michael Garone as Interim Chief Financial Officer
8:14am
S-8
EX-23.1
pb848
30 Aug 19
Registration of securities for employees
12:30pm
8-K
EX-10.1
vtu324y
27 Aug 19
Entry into a Material Definitive Agreement
8:39am
8-K
EX-10.1
0v8ajrr4x 39
1 Aug 19
New Executive Team Announced at Adaptimmune
7:22am
8-K
EX-99.1
k32pv nm7q0
25 Jul 19
Other Events
8:07am
8-K
EX-10.4
u9sf hnyhhqubasy
27 Jun 19
Departure of Directors or Certain Officers
8:08am
8-K
EX-10.1
cq7qz16u5v4hx8nsii1b
27 Jun 19
Departure of Directors or Certain Officers
8:08am